Ulcerative Colitis

Patients who adhere to health lifestyle choices, including those related to diet, exercise and smoking habits, had reduced mortality, according to study results.

As the concern about COVID-19 continues to spread, the entire medical community is on alert. Associations are cancelling or altering plans for scientific conferences, and institutions are implementing travel bans for faculty.

MAUI, Hawaii — Interleukin-23 inhibitors are effective for induction and maintenance of remission in Crohn’s disease and ulcerative colitis, according to an expert at the GUILD Conference 2020.

MAUI, Hawaii — Physicians should optimize and personalize the treatment algorithm for patients with inflammatory bowel disease, according to an expert at GUILD Conference 2020.

Etrasimod helped patients with moderate-to-severe ulcerative colitis achieve clinical and endoscopic improvements, according to research published in Gastroenterology.

Despite progress in treatment for inflammatory bowel disease, patients and providers reported differing expectations as to remission and other aspects of disease control in a recent global survey, as presented in a poster during the 2020 Congress of the European Crohn’s and Colitis Organisation.

Jami Kinnucan, MD, assistant professor at the University of Michigan, spoke with Healio about cannabis use among patients with ulcerative colitis and Crohn’s disease, the impact of diet on IBD management and the overall role of complementary therapy in the GI field, specifically for patients with IBD.

Feza Remzi, MD, FACS, FTSS(Hon), director of the Inflammatory Bowel Disease Center and professor of surgery at New York University Robert Grossman School of Medicine and NYU Langone Health, spoke with Healio about the importance of collaboration between surgeons and gastroenterologists, the role of ultrasonography for patients with Crohn’s disease in the United States and surgery’s place in the continuum of care.

MAUI, Hawaii — Certain inflammatory bowel disease therapies may further increase malignancies in patients with Crohn’s disease or ulcerative colitis, according to an expert at the GUILD Conference 2020.

MAUI, Hawaii — JAK inhibitors offer quick results, improved quality of life and lower serious adverse events for patients with inflammatory bowel disease, according to an expert at the GUILD Conference 2020.